Plerixafor Injection
Product Images NDC 70771-1776

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 70771-1776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 01)

Vial Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 01)
This text appears to be a description of a container closure for a medical product. The closure is stated to not be made with natural rubber latex. The product is an injection made in India and has a concentration of 5% with a specific dosage of 24 mg/1.2 mL (20 mg/mL). It is indicated for subcutaneous injection and comes in a single-dose vial. Any unused portion should be discarded. The last line is not readable and hence not available.*
FDA Label Image

Carton Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.